Profile
Linda Basse worked as a Medical Director at Genmab A, Topotarget A, and Zealand Pharma A.
She also served as the Chief Medical Officer at Medivir AB from 2018 to 2020.
Dr. Basse holds a doctorate degree from the University of Copenhagen.
Former positions of Linda Basse
| Companies | Position | End |
|---|---|---|
| MEDIVIR AB | Chief Tech/Sci/R&D Officer | 2020-09-29 |
| ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | - |
| TOPOTARGET A/S | Chief Tech/Sci/R&D Officer | - |
| GENMAB A/S | Chief Tech/Sci/R&D Officer | - |
Training of Linda Basse
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GENMAB A/S | Health Technology |
| MEDIVIR AB | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| Private companies | 1 |
|---|---|
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Stock Market
- Insiders
- Linda Basse
